Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prospective Translational Study Investigating Molecular PrEdictors of Resistance to First-Line PazopanIb in Metastatic reNal CEll Carcinoma (PIPELINE Study).
Sepe P, Martinetti A, Mennitto A, Verzoni E, Claps M, Raimondi A, Sottotetti E, Grassi P, Guadalupi V, Stellato M, Zattarin E, Di Maio M, Procopio G. Sepe P, et al. Among authors: guadalupi v. Am J Clin Oncol. 2020 Sep;43(9):621-627. doi: 10.1097/COC.0000000000000719. Am J Clin Oncol. 2020. PMID: 32889831 Free article.
Activity of sunitinib in patients with advanced neuroendocrine tumors.
Bajetta E, Guadalupi V, Procopio G. Bajetta E, et al. Among authors: guadalupi v. J Clin Oncol. 2009 Jan 10;27(2):319-20; author reply 320. doi: 10.1200/JCO.2008.20.3034. Epub 2008 Dec 8. J Clin Oncol. 2009. PMID: 19064950 No abstract available.
Neuroendocrine tumors (NETs).
Bajetta E, Procopio G, Guadalupi V, Del Vecchio M. Bajetta E, et al. Among authors: guadalupi v. Clin Ther. 2009 Sep;31(9):2060-1. doi: 10.1016/j.clinthera.2009.09.007. Clin Ther. 2009. PMID: 19843495 No abstract available.
Sequential use of sorafenib and sunitinib in advanced renal-cell carcinoma (RCC): an Italian multicentre retrospective analysis of 189 patient cases.
Porta C, Procopio G, Cartenì G, Sabbatini R, Bearz A, Chiappino I, Ruggeri EM, Re GL, Ricotta R, Zustovich F, Landi L, Calcagno A, Imarisio I, Verzoni E, Rizzo M, Paglino C, Guadalupi V, Bajetta E. Porta C, et al. Among authors: guadalupi v. BJU Int. 2011 Oct;108(8 Pt 2):E250-7. doi: 10.1111/j.1464-410X.2011.10186.x. Epub 2011 May 23. BJU Int. 2011. PMID: 21599821
Current Understanding of Urachal Adenocarcinoma and Management Strategy.
Claps M, Stellato M, Zattarin E, Mennitto A, Sepe P, Guadalupi V, Mennitto R, de Braud FGM, Verzoni E, Procopio G. Claps M, et al. Among authors: guadalupi v. Curr Oncol Rep. 2020 Jan 27;22(1):9. doi: 10.1007/s11912-020-0878-z. Curr Oncol Rep. 2020. PMID: 31989430 Review.
37 results